The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis

Journal of Urology

Volumn 159, Issue 6, 1998, Pages 1862-1867

  Parsons, C L ^a   Greenberger, Matthew ^a   Gabal, Lamia ^a   Bidair, Mohamed ^a   Barme, Gregory ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

Bladder; Potassium; Urinary tract infections

Indexed keywords

HEPARIN; POTASSIUM CHLORIDE; PROTAMINE;

ADULT; ARTICLE; BLADDER DISEASE; CONTROLLED STUDY; CYSTITIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; INTERSTITIAL CYSTITIS; INTRAVESICAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; URINARY TRACT INFECTION;

EID: 0032430642     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63178-1     Document Type: Article

References (28)

1. Parsons, C. L., Stein, P. C., Bidair, M. and Lebow, D.: Abnormal sensitivity to intravesical potassium in interstitial cystitis and radiation cystitis. Neurourol. Urodynam., 13: 515, 1994.
2. Teichman, J. M. H., Nielsen-Omeis, B. J. and McIver, B. D.: Modified urodynamics for interstitial cystitis. J. Urol., part 2, 155: 433A, abstract 491, 1996.
3. Payne, C. K. and Browning, S.: Graded potassium chloride testing in interstitial cystitis. J. Urol., part 2, 155: 438A, abstract 511, 1996.
4. Parsons, C. L., Lilly, J. D. and Stein, P.: Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J. Urol., 145: 732, 1991.
5. Lilly, J. D. and Parsons, C. L.: Bladder surface glycosaminoglycans is a human epithelial permeability barrier. Surg. Gynec. Obst., 171: 493, 1990.
6. Parsons, C. L., Boychuk, D., Jones, S., Hurst, R. and Callahan, H.: Bladder surface glycosaminoglycans: an epithelial permeability barrier. J. Urol., 143: 139, 1990.
7. Parsons, C. L., Stauffer, C. and Schmidt, J. D.: Bladder-surface glycosaminoglycans: an efficient mechanism of environmental adaptation. Science, 208: 605, 1980.
8. Parsons, C. L., Greenspan, C. and Mulholland, S. G.: The primary antibacterial defense mechanism of the bladder. Invest. Urol., 13: 72, 1975.
9. Parsons, C. L., Greenspan, C., Moore, S. W. and Mulholland, S. G.: Role of surface mucin in primary antibacterial defense of bladder. Urology, 9: 48, 1977.
10. Gill, W. B., Jones, K. W. and Ruggiero, K. J.: Protective effects of heparin and other sulfated glycosaminoglycans on crystal adhesion to injured urothelium. J. Urol., 127: 152, 1982.
11. 99mtechnetium-diethylenetriaminepentaacetic acid. J. Urol., 151: 346, 1994.
12. Parsons, C. L.: Epithelial coating techniques in the treatment of interstitial cystitis. Urology, suppl., 49: 100, 1997.
13. Hohlbrugger, G. and Lentsch, P.: Intravesical ions, osmolality and pH influence the volume pressure response in the normal rat bladder, and this is more pronounced after DMSO exposure. Eur. Urol., 11: 127, 1985.
14. Hohlbrugger, G.: The vesical blood-urine barrier: a relevant and dynamic interface between renal function and nervous bladder control. J. Urol., 154: 6, 1995.
15. Mulholland, S. G., Hanno, P., Parsons, C. L., Sant, G. R. and Staskin, D. R.: Pentosan polysulfate sodium for therapy of interstitial cystitis. A double-blind, placebo-controlled clinical study. Urology, 35: 552, 1990.
16. Fritjofsson, A., Fall, M., Juhlin, R., Persson, B. E. and Ruutu, M.: Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multi-center trial. J. Urol., 138: 508, 1987.
17. Holm-Bentzen, M., Jacobsen, F., Nerstrom, B., Lose, G., Kristensen, J. K., Pederson, R. H., Krarup, T. Feggetter, J., Bates, P.., Barnard, R., Larsen, S. and Hald, T.: A prospective double-blind clinically controlled multi-center trial of sodium pentosanpolysulfate in the treatment of interstitial cystitis and related painful bladder disease. J. Urol., 138: 503, 1987.
18. Parsons, C. L., Housley, T., Schmidt, J. D. and LeBow, D.: Treatment of interstitial cystitis with intravesical heparin. Brit. J. Urol., 73: 504, 1994.
19. Parsons, C. L., Benson, G., Childs, S. J., Hanno, P., Sant, G. R. and Webster, G.: A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosanpolysulfate. J. Urol., 150: 845, 1993.
20. Oravisto, K. J., Alfthan, O. S. and Jokinen, E. J.: Interstitial cystitis. Clinical and immunological findings. Scand. J. Urol. Nephrol., 4: 37, 1970.
21. Hanash, K. A. and Pool, T. L.: Interstitial and hemorrhagic cystitis: viral, bacterial and fungal studies. J. Urol., 104: 7056, 1970.
22. Oravisto, K. J. and Alfthan, O. S.: Treatment of interstitial cystitis with immunosuppression and chloroquine derivatives. Eur. Urol., 2: 82, 1976.
23. Silk, M. R.: Bladder antibodies in interstitial cystitis. J. Urol., 103: 307, 1970.
24. Holm-Bentzen, J. and Lose, G.: Pathology and pathogenesis of interstitial cystitis. Urology, suppl. 4, 29: 8, 1987.
25. Oravisto, K. J.: Interstitial cystitis as an autoimmune disease. A review. Eur. Urol., 6: 10, 1980.
26. Weaver, R. G., Dougherty, T. F. and Natoli, C. A.: Recent concepts of interstitial cystitis. J. Urol., 89: 377, 1963.
27. Lotz, M., Villiger, P., Hugli, T., Koziol, J. and Zuraw, B. L.: Interleukin-6 and interstitial cystitis. J. Urol., 152: 869, 1994.
28. Nigro, D. A., Wein, A. J., Foy, M., Parsons, C. L., Williams, M., Nyberg, L. M., Jr., Landis, J. R., Matthew Cook, Y. L. and Simon, L. J.: Associations among cystoscopic and urodynamic findings for women enrolled in the Interstitial Cystitis Data Base (ICDB) Study. Urology, suppl., 49: 86, 1997.